 |
Tositumomab and iodine I 131 tositumomab |
|---|---|
| Trade Name | Bexxar |
| Orphan Indication | Non-Hodgkin's B-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 1994-05-16 00:00:00 |
| Sponsor | GlaxoSmithKline LLC;Corporation Service Company, 2711 Centerville Road, Suite 400;Wilmington, Delaware, 19808 |
